Synthesis and anti-proliferative activity of N,N’-bis-substituted -2,4-triazolium salts with various substituents


The need for a more desirable anti-tumor agent with fewer side effect is urgent to solve the issue of cancer which is currently one of the leading causes of death in the United States. Recently, imidazolium and benzimidazolium salts have been discovered to possess comparable anti-proliferative activity to cisplatin, a FDA approved drug. Triazolium salts, closely related to the imidazolium and benzimidazolium salts, has yet to be discovered to exhibit any anti-proliferative activity yet. A series of N,N’-bis-substituted triazolium salts are synthesized, characterized, and tested for solubility and anti-proliferative activity against a panel of breast and prostate cancer cell lines.


Funded by a Student Research and Creative Endeavors Grant from Columbus State University and CSU Department of Chemistry. Thank you also to Spelman College.

This document is currently not available here.